Form 4: cbdMD Director William F. Raines III Acquires Shares and Options as Part of Compensation Package
SEC Form 4
Director William F. Raines III acquired 4,000 shares of common stock and 2,000 stock options in cbdMD, Inc. as part of his compensation for serving on the Board of Directors.
Summary
- William F. Raines III, a director of cbdMD, Inc., reported changes in beneficial ownership of the company's securities.
- On March 29, 2024, Raines acquired 4,000 shares of common stock and 2,000 stock options.
- The common stock was acquired at a price of $0 per share, and the director disposed of 9,256 shares.
- The stock options have an exercise price of $0.93 and are fully vested, expiring on March 29, 2029.
- These transactions were part of Raines' compensation for serving on the Board of Directors, approved by the Issuer's Compensation, Corporate Governance and Nominating Committee.
- The restricted stock units vest quarterly on June 30, 2024, September 30, 2024, December 31, 2024 and March 31, 2025.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of director compensation and stock ownership changes. The acquisition of shares and options is a positive sign, but the disposal of shares is a negative sign.
Positives
- The acquisition of shares and options demonstrates the director's continued investment in the company.
- The compensation package was approved by the Issuer's Compensation, Corporate Governance and Nominating Committee, indicating proper governance procedures.
Negatives
- The director disposed of 9,256 shares of common stock.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the compensation and ownership structure of the company's leadership.
Comparison to Industry Standards
- Director compensation packages often include a mix of salary, stock options, and restricted stock units.
- The vesting schedule and exercise price of the options are typical for similar companies in the industry.
- Comparing the size of the grant to those of directors at companies like Charlotte's Web or Cronos Group would provide further context.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding director compensation and ownership.
- The vesting schedule of the restricted stock units aligns the director's interests with the long-term performance of the company.
Key Dates
| Date | Description |
|---|---|
| 03/29/2024 | Date of transaction: acquisition of common stock and stock options. |
| 03/29/2029 | Expiration date of the stock options. |
| 06/30/2024 | First vesting date for restricted stock units. |
| 09/30/2024 | Second vesting date for restricted stock units. |
| 12/31/2024 | Third vesting date for restricted stock units. |
| 03/31/2025 | Final vesting date for restricted stock units. |
| 04/02/2024 | Date of signature. |
Keywords
cbdMD, Director, Stock Options, Common Stock, Beneficial Ownership, Compensation, YCBD, Raines
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.